|
|
|
|
Promising Clinical Data on Gen-Probe's APTIMA HPV Test Presented at Major European Medical Meeting
Gen-Probe's (NASDAQ:GPRO) CE-marked APTIMA HPV assay may be an important new molecular tool to more accurately detect high-risk human papillomavirus (HPV) infections that are associated with cervical cancer or precancerous...
|
|
|
Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting
- New, CE-Marked Molecular Assay May Help Identify Women with Cervical Cancer or Pre-Cancer More Accurately than Competing Technologies, Studies Show - SAN DIEGO, Nov.21 /PRNewswire-FirstCall/ -- Gen-Probe's CE-marked APTIMA(R) HPV...
|
|
|
Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting
- New, CE-Marked Molecular Assay May Help Identify Women with Cervical Cancer or Pre-Cancer More Accurately than Competing Technologies, Studies Show - SAN DIEGO, Nov.21 /PRNewswire-FirstCall/ -- Gen-Probe's CE-marked APTIMA(R) HPV...
|
|
|
Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting
- New, CE-Marked Molecular Assay May Help Identify Women with Cervical Cancer or Pre-Cancer More Accurately than Competing Technologies, Studies Show - SAN DIEGO, Nov.21 /PRNewswire-FirstCall/ -- Gen-Probe's CE-marked APTIMA(R) HPV...
|
|
|
Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting
SAN DIEGO, Nov.21 /PRNewswire-FirstCall/ -- Gen-Probe's CE-marked APTIMA(R) HPV assay may be an important new molecular tool to more accurately detect high-risk human papillomavirus (HPV) infections that are associated with...
|
|
|
Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting
- New, CE-Marked Molecular Assay May Help Identify Women with Cervical Cancer or Pre-Cancer More Accurately than Competing Technologies, Studies Show - SAN DIEGO, Nov.21 /PRNewswire-FirstCall/ -- Gen-Probe's CE-marked APTIMA(R) HPV...
|
|
|
Merck's HPV Vaccine Gardasil Demonstrates Efficacy In Males In Late-stage Study
Merck & Co.(MRK: News ) announced that its cervical cancer vaccine, Gardasil demonstrated efficacy in preventing HPV (human papillomavirus)-related disease in males in a late-stage study. In the phase III study, Gardasil was...
|
|
|
Hologic Releases the Results of the CervistaT HPV Clinical Trials
Hologic, Inc.(NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the results of the...
|
|
|
Identification of women with HPV types could improve early intervention to stop cervical cancer
As testing for high-risk types of the human papillomavirus (HPV) emerges as the gold standard in cervical cancer prevention, scientists are already researching how to determine even more precisely who is most likely to develop the...
|
|
|
Researchers say identifying women with HPV types 16, 18 and 45 could improve early intervention to stop cervic
Women's Health News As testing for high-risk types of the human papillomavirus (HPV) emerges as the gold standard in cervical cancer prevention, scientists are already researching how to determine even more precisely who is most likely...
|
|
|
Data suggest Merck & Co.'s Gardasil prevents HPV-related disease in boys and men
Late-stage study data presented at the European Research Organization on Genital Infection and Neoplasia conference on Thursday suggest that, compared with placebo, Merck & Co.'s Gardasil prevented 90 percent of external...
|
|
|
GARDASIL, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males
ical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study WHITEHOUSE STATION, N.J., Nov.13, 2008 - GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine,...
|
|
|
Cervical cancer vaccine can protect men from HPV
WASHINGTON (Reuters) - A vaccine designed to protect women and girls from cervical cancer caused by a virus that also causes genital warts may protect men, too, maker Merck and Co reported on Thursday.The Gardasil vaccine was 90 percent...
|
|
|
GARDASIL(R), Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males
WHITEHOUSE STATION, N.J.-- (BUSINESS WIRE) -- GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], the cervical cancer vaccine from Merck & Co., Inc., prevented 90 percent of external genital...
|
|
|
GARDASIL, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males i
Pivotal Study Evaluating Efficacy of GARDASIL in Males in Preventing HPV 6, 11, 16 and 18-Related External Genital Lesions WHITEHOUSE STATION, N.J., Nov.13, 2008 -(HSMN NewsFeed)--GARDASIL [Human Papillomavirus Quadrivalent ...
|
|
|
Study: HPV Vaccine Prevents Genital Warts in Males
ATLANTA -- For the first time, an expensive vaccine aimed at preventing cervical cancer in women has proven successful at preventing a disease in men, according to a study released Thursday by the vaccine's maker.The disease is genital...
|
|
|
Merck Says HPV Vaccine Prevents Genital Warts in Men
For the first time, an expensive vaccine aimed at preventing cervical cancer in women has proven successful at preventing a disease in men, according to a study released Thursday by the vaccine's maker.The disease is genital warts...
|
|
|
Study: HPV Vaccine Prevents Genital Warts in Males
ATLANTA (AP) -- For the first time, an expensive vaccine aimed at preventing cervical cancer in women has proven successful at preventing a disease in men, according to a study released Thursday by the vaccine's maker.The disease is...
|
|
|
Study: HPV Vaccine Prevents Genital Warts in Males
ATLANTA, GA (AP) -- For the first time, an expensive vaccine aimed at preventing cervical cancer in women has proven successful at preventing a disease in men, according to a study released Thursday by the vaccine's maker.The disease is...
|
|
|
HPV Vaccine Gardasil May Help Boys, Men
Study: Gardasil May Reduce Risk of Genital Warts in Men Nov.13, 2008 -- Gardasil, a vaccine against four strains of human papillomavirus (HPV), may help prevent genital warts in boys and men. That's according to a new...
|
|
|
Health Highlights: Nov. 15, 2008
Medical Panel Recommends $60 Million for Gulf War Illness Research While the U.S.government is trying to handle the injuries and ailments suffered by thousands of Armed Services veterans returning from Iraq and Afghanistan, an advisory...
National Womens Health Information Center:
Nov 15 2008 7:08PM
Matching: genital warts hpv
|
Find similar documents
|
|
|
|
New study shows Gardasil reduces HPV-related diseases in men
Gardasil [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], 'the HPV vaccine', prevented 90 per cent of external genital lesions, including genital warts caused by HPV types 6, 11, 16 and 18 in a...
|
|
|
Study: HPV Vaccine Prevents Genital Warts In Men
Study: HPV Vaccine Prevents Genital Warts In Men Required fields are marked with an asterisk(*) Recipient E-mail:* Your Name:* Your E-mail:* Add a Message: Send me a copy of this e-mail.Type the characters in this...
|
|
|
Study: HPV Vaccine Prevents Genital Warts In Men
Study: HPV Vaccine Prevents Genital Warts In Men Required fields are marked with an asterisk(*) Recipient E-mail:* Your Name:* Your E-mail:* Add a Message: Send me a copy of this e-mail.Type the characters in this...
|
|
|
Study: HPV Vaccine Prevents Genital Warts In Men
Study: HPV Vaccine Prevents Genital Warts In Men Required fields are marked with an asterisk(*) Recipient E-mail:* Your Name:* Your E-mail:* Add a Message: Send me a copy of this e-mail.Type the characters in this...
|
